Healthcare provider profile · identity verified

David W Hunt, DO

Family Practice · NEW PORT RICHEY, FL · NPI 1093754657

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	336	203
Atorvastatin Calcium	Atorvastatin Calcium	266	165
Lisinopril	Lisinopril	228	140
Amlodipine Besylate	Amlodipine Besylate	211	120
Levothyroxine Sodium	Levothyroxine Sodium	209	114
Omeprazole	Omeprazole	198	109
Metformin Hcl	Metformin Hcl	156	87
Albuterol Sulfate Hfa	Albuterol Sulfate	150	73
Losartan Potassium	Losartan Potassium	140	83
Gabapentin	Gabapentin	122	71
Metoprolol Tartrate	Metoprolol Tartrate	100	60
Metoprolol Succinate	Metoprolol Succinate	93	51
Hydrochlorothiazide	Hydrochlorothiazide	90	48
Tamsulosin Hcl	Tamsulosin Hcl	88	58
Pantoprazole Sodium	Pantoprazole Sodium	83	50
Furosemide	Furosemide	82	56
Alprazolam	Alprazolam	80	49
Eliquis	Apixaban	70	30
Alendronate Sodium	Alendronate Sodium	69	40
Trazodone Hcl	Trazodone Hcl	68	46
Prednisone	Prednisone	67	50
Simvastatin	Simvastatin	66	34
Tramadol Hcl	Tramadol Hcl	63	31
Citalopram Hbr	Citalopram Hydrobromide	58	31
Glimepiride	Glimepiride	57	38
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	28
Clopidogrel	Clopidogrel Bisulfate	50	34
Duloxetine Hcl	Duloxetine Hcl	50	29
Pioglitazone Hcl	Pioglitazone Hcl	48	30
Sertraline Hcl	Sertraline Hcl	45	26
Allopurinol	Allopurinol	44	26
Amoxicillin	Amoxicillin	44	41
Escitalopram Oxalate	Escitalopram Oxalate	43	29
Potassium Chloride	Potassium Chloride	40	20
Carvedilol	Carvedilol	39	28
Ibuprofen	Ibuprofen	38	30
Glipizide Er	Glipizide	36	25
Azithromycin	Azithromycin	35	32
Meloxicam	Meloxicam	34	26
Famotidine	Famotidine	33	18
Oxybutynin Chloride	Oxybutynin Chloride	33	16
Valsartan	Valsartan	33	22
Finasteride	Finasteride	32	21
Jardiance	Empagliflozin	32	19
Cefuroxime	Cefuroxime Axetil	30	28
Wixela Inhub	Fluticasone Propion/Salmeterol	28	17
Atenolol	Atenolol	26	20
Xarelto	Rivaroxaban	26	14
Pravastatin Sodium	Pravastatin Sodium	25	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	11
Montelukast Sodium	Montelukast Sodium	24	19
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Spironolactone	Spironolactone	24	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	23
Glipizide	Glipizide	23	16
Sildenafil Citrate	Sildenafil Citrate	19	11
Temazepam	Temazepam	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Levofloxacin	Levofloxacin	17	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Tadalafil	Tadalafil	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	11
Labetalol Hcl	Labetalol Hcl	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Pregabalin	Pregabalin	15	suppressed
Baclofen	Baclofen	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	11
Diazepam	Diazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Digoxin	Digoxin	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Lorazepam	Lorazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error